`
`BEFORE THE PATENT TRLAL AND APPEAL BOARD
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`
`Petitioner,
`
`ANACOR PHARMACEUTICALS, INC.,
`
`Patent Owner.
`
`Case No. IPR2015—O1776
`
`Patent No. 7,582,621
`
`PATENT OWNER ANACOR PHARNIACEUTICALS, INC.’S
`NOTICE OF DEPOSITION OF STEPHEN B. KAHL, Ph.D.
`
`DC: 6012423~2
`
`
`
`Docket No. 036914.0005—US01
`
`IPR2015—01776
`
`By this Notice, pursuant to 37 C.F.R. § 42.53, and through prior agreement
`
`with counsel for Petitioner Coalition for Affordable Drugs X LLC, Patent Owner
`
`Anacor Pharmaceuticals, Inc. will conduct cross—eXamination by deposition of Dr.
`
`Stephen B. Kahl, beginning at 9:00 am on April 7, and continuing on April 8, at
`
`the offices of Covington & Burling LLP, One Front Street, San Francisco,
`
`California, 94111 (the “Deposition”).
`
`The Deposition is being conducted based on the declarations of Dr. Kahl as
`
`filed in each of the three proceedings between the parties: IPR2015-01776,
`
`IPR2015—01780 and IPR20l5—0785. Therefore, the parties agree that, should
`
`additional time within the maximum total time for cross-examination of 21 hours
`
`be needed, an additional day will be scheduled. The parties further agree that the
`
`entire cross—examination testimony from the Deposition will be filed in each of the
`
`three proceedings.
`
`Pursuant to 37 C.F.R. § 42.53, and through prior agreement of the parties,
`
`the Deposition shall be taken before a duly authorized notary public or other
`
`officer authorized to administer oaths and will be recorded by audiotape and/or
`
`stenographic means.
`
`
`
`Docket No. 0369140005-US01
`
`IPR2015—01776
`
`
`Date: March 25 2016
`
`Respectfully submitted,
`
`//4
`
`“t
`
`
`By
`
`An rea G. R
`,?W/
`Registration No?’36,253
`Paul J. Berman
`
`Registration No. 36,744
`Christopher K. Eppich
`Registration No. 52,868
`Enrique D. Longton
`Registration No. 47,304
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 25th day of March 2016,
`
`the foregoing Patent Owner Anacor Pharmaceuticals, Inc.’s Notice of Deposition
`
`of Stephen B. Kahl, Ph.D. was served by electronic mail, by agreement of the
`
`parties, on the following counsel of record for petitioner.
`
`Jeffrey D. Blake
`Kathleen E. Ott
`
`Peter A. Gergely
`Ryan James Fletcher
`Brent E. Routman
`
`Merchant & Gould PC
`
`KerydinIPR@merchantgould.com
`
`Date: March 25, 2016
`
`Reg. No.: 36,2 3